Possibia

1684943

Last Update Posted: 2019-12-12

Recruiting has ended

All Genders

accepted

18 Years +

33 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling

The investigators are doing this research study to compare the pharmacokinetics (PK) (rate of absorption) of insulin lispro (Humalog), insulin aspart (Novolog), and insulin glulisine (Apidra) within individual subjects.

Additionally, the investigators will perform a preliminary feasibility evaluation of a minimally invasive continuous insulin monitoring (CIM) device and its use to derive PK parameters in human subjects.

Eligibility

Relevant conditions:

Type 1 Diabetes

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov